InMode (INMD) Dips More Than Broader Markets: What You Should Know

- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -

InMode (INMD) closed at $21.98 in the latest trading session, marking a -0.86% move from the prior day. This change lagged the S&P 500’s daily loss of 0.16%. Meanwhile, the Dow lost 0.12%, and the Nasdaq, a tech-heavy index, lost 0.33%.

Prior to today’s trading, shares of the maker of cosmetic surgery devices had lost 19.62% over the past month. This has lagged the Medical sector’s loss of 8.16% and the S&P 500’s loss of 10.5% in that time.

Investors will be hoping for strength from INMD as it approaches its next earnings release

INMD’s full-year Zacks Consensus Estimates are calling for earnings of $1.86 per share and revenue of $194.79 million. These results would represent year-over-year changes of +14.11% and +24.58%, respectively.

Investors should also note any recent changes to analyst estimates for INMD. These revisions help to show the ever-changing nature of near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company’s business outlook.

Based on our research, we believe these estimate revisions are directly related to near-team stock moves. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.

The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. INMD is currently a Zacks Rank #1 (Strong Buy).

Looking at its valuation, INMD is holding a Forward P/E ratio of 11.92. This valuation marks a discount compared to its industry’s average Forward P/E of 24.63.

Home of Science
Follow me

- Advertisement -

Discover

Sponsor

Latest

Google braved one recession, and Alphabet is more diversified as coronavirus roils rivals

This article is part of a series tracking the effects of the COVID-19 pandemic on major businesses, and will be updated. It was originally...

Mesothelioma Causes – It’s A Medical Condition That Can Be Prevented

Mesothelioma Causes - It's A Medical Condition That Can Be PreventedMesothelioma causes cancer of the protective lining in the chest of humans. The...

Should You Work With Jeff Bezos?

Before we look at the Amazon.com website and see whether or not it is a legitimate business or just another scam, let's consider whether...

Black Hottie Who is Loved by Everyone – Finally

Black Hottie Who is Loved by Everyone - FinallyAmong the first women who I admired when I first began watching TV and magazine...

SilverCloud’s $16M Series B to Boost North American Expansion

Nothing says “we believe in what you are doing” more than four entities investing in a company many of their associates currently recommend. SilverCloud Health’s...
Home of Science
Follow me